The Oncology Institute, Inc. (NASDAQ:TOIIW) Sees Large Decrease in Short Interest

The Oncology Institute, Inc. (NASDAQ:TOIIW) was the recipient of a significant decrease in short interest in January. As of January 31st, there was short interest totalling 2,700 shares, a decrease of 38.6% from the January 15th total of 4,400 shares. Based on an average daily volume of 28,000 shares, the short-interest ratio is currently 0.1 days.

Oncology Institute Stock Performance

Shares of NASDAQ:TOIIW opened at $0.04 on Thursday. Oncology Institute has a 52 week low of $0.01 and a 52 week high of $0.31. The company has a 50-day moving average price of $0.02 and a 200 day moving average price of $0.02.

About Oncology Institute

The Oncology Institute, Inc, an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, and counseling services.